OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases
Pan Shen, Xuan Deng, Zhe Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 62

Immunopharmacological Activities of Luteolin in Chronic Diseases
Lei Huang, Mi‐Yeon Kim, Jae Youl Cho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2136-2136
Open Access | Times Cited: 59

Mitochondrial dysfunction and therapeutic perspectives in osteoporosis
Jialing Liu, Zhonghua Gao, Xiangjie Liu
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 19

Sirtuins in kidney health and disease
Luca Perico, Giuseppe Remuzzi, Ariela Benigni
Nature Reviews Nephrology (2024) Vol. 20, Iss. 5, pp. 313-329
Closed Access | Times Cited: 17

Natural medicines of targeted rheumatoid arthritis and its action mechanism
Xueling Liu, Zhiguo Wang, Hua Qian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63

Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment
Aranka Brockmueller, Constanze Buhrmann, Parviz Shayan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27

Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation
Mingming Zhang, Zhiyin Tang
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114474-114474
Open Access | Times Cited: 25

The Role of Sirtuin 1 (SIRT1) in Neurodegeneration
Daniel Razick, Muzammil Akhtar, Jimmy Wen, et al.
Cureus (2023)
Open Access | Times Cited: 25

Sirtuin family in autoimmune diseases
Zhengjie Tao, Zihan Jin, Jiabiao Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25

Sirtuins in kidney diseases: potential mechanism and therapeutic targets
Qi Jin, Fang Ma, Tong‐Tong Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11

Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction
Changhui Zhu, Xue Dong, Xiwei Wang, et al.
Genetics Research (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 35

Pharmacological roles of lncRNAs in diabetic retinopathy with a focus on oxidative stress and inflammation
Cheng-Ming Chen, Peng Ding, Weiming Yan, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115643-115643
Closed Access | Times Cited: 20

Exosomes secreted by mesenchymal stem cells delay brain aging by upregulating SIRT1 expression
Xiaowen Zhang, Te Liu, Xuejia Hou, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18

Sirt1 inhibits macrophage polarization and inflammation in gouty arthritis by inhibiting the MAPK/NF-κB/AP-1 pathway and activating the Nrf2/HO-1 pathway
Xu Zhao, Menglan Li, Yiwei Lu, et al.
Inflammation Research (2024) Vol. 73, Iss. 7, pp. 1173-1184
Open Access | Times Cited: 8

SIRT1: An Intermediator of Key Pathways Regulating Pulmonary Diseases
Yi-Zhu Jiang, Xinran Huang, Jing Chang, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 5, pp. 102044-102044
Closed Access | Times Cited: 7

Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases
Bo Han, Mengfei Wang, Jiayi Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115613-115613
Closed Access | Times Cited: 16

LncRNA GAS5 suppresses inflammatory responses by inhibiting HMGB1 release via miR-155-5p/SIRT1 axis in sepsis
Zhuo Zeng, Yingying Lan, Yu Chen, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175520-175520
Closed Access | Times Cited: 13

Mitochondrial sirtuin 3 and role of natural compounds: the effect of post-translational modifications on cellular metabolism
Francesca Oppedisano, Salvatore Nesci, Anna Spagnoletta
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 3-4, pp. 199-220
Closed Access | Times Cited: 5

Aspirin‐Mediated Acetylation of SIRT1 Maintains Intestinal Immune Homeostasis
Liangguo Xie, Chaoqun Li, Chao Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 4

Ferulic Acid Reduces Inflammatory Response Induced by Radiation through Sirt1-NLRP3 Pathway
Yao Nie, Mingyue Huang, Tingyu Yang, et al.
Acupuncture and Herbal Medicine (2024) Vol. 4, Iss. 3, pp. 367-374
Open Access | Times Cited: 4

Gut microbiota as a sensor of autoimmune response and treatment for rheumatoid arthritis
Abhinav Lamba, Veena Taneja
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 90-106
Closed Access | Times Cited: 4

Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases
Xiaolong Yu, Mingkai Chen, Jiabiao Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

TBK1 pharmacological inhibition mitigates osteoarthritis through attenuating inflammation and cellular senescence in chondrocytes
Rui Lu, Yunkun Qu, Zhenggang Wang, et al.
Journal of Orthopaedic Translation (2024) Vol. 47, pp. 207-222
Open Access | Times Cited: 4

Autoimmune disease: a view of epigenetics and therapeutic targeting
S. Y. Mu, Wanrong Wang, Qiuyu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top